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Treatment options for symptomatic lumbar spinal stenosis are limited in elderly patients. Injection
therapies, such as lumbar epidural steroid injections, are one accepted alternative; however, objective
evidence is usually not reported. We describe the use of the Short Physical Performance Battery (SPPB)
and step count monitoring for the ﬁrst time to demonstrate physical improvements in our patient with
lumbar stenosis. The patient underwent two lumbar epidural steroid injections. Pain scores, the SPPB,
and step count monitoring were measured at baseline and prior to and after each injection. Improve-
ments were noted in the numerical pain score, the walk test, and the step count.
Copyright © 2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Degenerative lumbar spine disease can present with low back
pain and pain radiating unilaterally or bilaterally into the buttocks
and legs secondary to inﬂammation, nerve compression, and
possible ischemia. Changes in the lumbar spine, such as thickening
of the ligamentum ﬂavum, osteoarthritis of the facet joints, and disc
degeneration, are considered the underlying pathology.1,2
Symptoms are exacerbated by activities such as walking and
standing. These symptoms result in signiﬁcant functional impair-
ment, which, if left untreated, can lead to the risk of losing inde-
pendence secondary to pain and loss of physical function. This
disease process is most prominent in patients older than 60 years, a
population that is expected to rise by 25% of the total population
within the next 2 decades.1,2siology, University of Texas
, TX 77555-0591, USA.
linical Gerontology & Geriatrics. PVarious treatment options have been postulated, including ex-
ercise, medication management, epidural steroid injections, and
surgical decompression and fusion. The overall goal is to maintain
the functional level of the patient.3,4 This case report describes the
effects of a lumbar epidural steroid injection on lower extremity
functioning and overall physical activity using the Short Physical
Performance Battery (SPPB; timed walkingmeasurement, chair rise
test, standing balance) and accelerometer-derived step count
monitoring. Numeric pain scores were also assessed.2. Case report
2.1. Patient
The patient was a 72-year-oldmalewith a bodymass index of 35
presenting with symptomatic lumbar degenerative spine disease
with lower back and leg pain. His past medical history was negative
for spine surgery or interventions; his remaining history was
noncontributory. He described his lower back pain as aching and
the pain radiating into the posteriorelateral aspect of his right legublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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aggravated with activity and slowly progressed over the previous
12 months. The diagnosis was conﬁrmed clinically as well as with
imaging studies. Lumbar magnetic imaging studies demonstrated
multilevel degenerative changes most pronounced at the L4/5 and
L5/S1 levels, with canal and foraminal narrowing secondary to disc
disease and facet, as well as ﬂavum hypertrophy. The patient gave
consent to publish this study. The outcome measures were also
approved by the University of Texas Medical Branch (UTMB; Gal-
veston, TX, USA) Institutional Review Board (Protocol 12-160).Fig. 1. Gait speed and step count percentage improvement.2.2. Treatment
The patient was treated with hydrocodone/acetaminophen 10/
325 mg (Norco, Watson Pharmaceuticals, Corona, CA, USA) twice
daily and tramadol 50mg (Ultram, Janssen Pharmaceuticals, Beerse,
Belgium) every 6 hours by his referring physicians. He did not want
to escalate his medication regimen and subsequently underwent
two lumbar epidural steroid injections over the course of 3 months,
as his symptoms returned after the ﬁrst injection. The ﬁrst lumbar
epidural steroid injection was performed at the L4/5 level, and
10mg of dexamethasone (Fresenius Kabi, Lake Zurich, Illinois, USA)
was injected under ﬂuoroscopic guidance and local anesthesia. The
second injection was performed with a similar technique, except
that a right transforaminal injection at the L5 foramen was per-
formed and a total of 10 mg of dexamethasone was injected. Ofﬁce
visits with injections were 3 weeks apart during the study period.2.3. Outcome measures
The SPPB,5 accelerometry-derived step counts (for 6 days), and
self-reported pain scores (see descriptions below) were measured
at baseline and prior to and after each injection. Percentage im-
provements pre- and post-interventions were calculated for each
component of the SPPB, mean step counts, and the numeric pain
score.
The SPPB includes three objective tests of lower body function:
(1) a timed 4-meter walk; (2) ﬁve timed, repetitive chair stands;
and (3) a hierarchical test of standing balance.5 The SPPB summary
score is created by summing the three individual test items ac-
cording to previously established criteria.4 There is a potential
range of 0e12, with higher scores indicating better lower body
function. The patient's baseline SPPB summary score was 8. There
was an overall 14% improvement in the 4-meter walk test after the
ﬁrst injection and a 37% improvement after the second injection
(Table 1 and Fig. 1). The chair rise and balance tests did not change
pre/post intervention (Table 1). The patient's SPPB summary score
improved to 9 at the end of his treatment.
The accelerometer usedwas a small (70mm 50mm 20mm;
1.3 oz), dual axis, ankle-worn device attached loosely with a Velcro
strap. It is programmed and read via a computer docking station,
and is impervious to tampering. Step detection accuracy exceedsTable 1









Pain score (0e10/10) 5 2 7 4
Pedometer steps
(mean/6 days)
4118 4669 2872 4260
4-meter walk test (s) 5 4.3 6.5 4.1
Chair-rise test (s) 14.3 15 13 12.3
Balance test
(normal/impaired)
Normal Normal Normal Normal96% even in clinical populations.6 The patient was instructed to
wear the monitor during all waking hours. Mean step counts for 6
days improved 13% after the ﬁrst injection and 48% after the second
injection (Table 1 and Fig. 1).
His quantitative pain was recorded using the numerical pain
score (from 0 ¼ no pain to 10 ¼maximum pain). The improvement
after his ﬁrst injection was 40% and it increased to 43% after the
second injection (Table 1).
During the course of the study, he was able to wean himself off
the hydrocodone and was only taking tramadol 50 mg once, on
occasion, twice daily.3. Discussion
Symptom control is the treatment goal for painful degenerative
lumbar spine disease. The injection of epidural steroids under
ﬂuoroscopic guidance is one accepted intervention.4 It is thought
that the steroid injected into the epidural space will decrease the
inﬂammation and nerve irritation caused by the degenerative
changes.4 This intervention is usually tolerated well, can be per-
formed in the ambulatory setting without general anesthesia, and
has a very low complication rate with <1% having complications
such as infection or neurological injury.4
However, the injections do not provide a permanent “cure,”
which has been criticized in studies.7e9 Given that the underlying
degenerative changes are usually not reversible, this is not sur-
prising.7e9 Therefore, epidural steroid injection for degenerative
spine disease should be more regarded as a “maintenance therapy,”
because it can be repeated based on symptomatology. Based on the
amount of steroids injected, the injection could be repeated every
8e12 weeks to avoid adrenal suppression, although injections can
be performed in a shorter time period if the injection therapy was
just initiated.4
The decision on whether or not the injection was successful is
usually based on patient reports of pain scores and changes in the
use of pain medications.7e9 The impact on function is reported in
self-perceived questionnaires rather than objective measure-
ments.10 Because lumbar degenerative spine disease frequently
impairs the function of the lower extremities, including walking,
functional measures should be developed and used in clinical
practice to address this lack of knowledge.11
The team of Tomkins-Lane11 recently published a study
measuring physical function with objective measures for research
purposes. Seventeen patients undergoing a lumbar epidural steroid
injection for lumbar spine stenosis were studied. A combination of
subjective measures, such as the Oswestry Disability Index and the
Swiss Spinal Stenosis Questionnaire, and physical performance
measures, such as the Self-PacedWalking Test (SPWT), were used.11
Performance at homewasmeasuredwith accelerometers for 7 days
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week after injection. The authors found signiﬁcant improvements
in self-report questionnaires including perceived physical function;
however, ﬁndings on objectively measured performance tests
(SPWT and accelerometer) demonstrated nonsigniﬁcant improve-
ments. Tomkins-Lane et al11 decided to use only one time point as
follow up, and one can speculate if further follow-up examinations
would have demonstrated a more dynamic response. Whereas the
questionnaires and the accelerometer could be used in clinical
practice, the SPWT involves a walking test of 4 meters, which is not
feasible in most clinical settings. Nevertheless, this was one of the
ﬁrst studies using objective measures to access function.11
Although the combination of the SPPB and accelerometer has
not been used in ambulatory pain patients undergoing injection
therapy, both measures have been used for other clinical pop-
ulations.5,6 The SPPB has been used to evaluate physical perfor-
mance in acutely hospitalized patients and healthy, nonclinical
populations. Guralnik et al5 described the use of the SPPB in >5000
older men and women living in the community. He found a strong
correlation between SPPB score and the risk of death or nursing
home admissionwithin 5 years. Fisher et al12 used the SPPB in older
hospitalized patients. Ninety patients aged 65 years and older were
assessed within 24 hours of hospital admission. Age, comorbidities,
length of stay, and cognition were signiﬁcantly and inversely
correlated with the SPPB score. Both studies demonstrated the
feasibility of the SPPB in hospital and ambulatory settings.
The current case was conducted in the outpatient setting, and
we can conﬁrm the ease of administration of the SPPB in a busy
clinic. Additionally, a one-point improvement in the SPPB summary
score, as seen in our patient, has been shown to be clinically
meaningful and correlated well with increases in overall activity.5
This case is also among the ﬁrst to describe the combination of
the SPPB, which provides one time point of physical performance
with accelerometry to assess overall activity over an extended
period of time. Improvements in pain scores, the SPPB, and step
activity were seen in our patient after each injection. In addition,
we found clinically useful information from the decrease in activity
and performance with both instruments after the beneﬁcial effect
of the ﬁrst epidural steroid injection faded.
We studied only one patient, which is a limitation of our
investigation, however, this report is suitable to distribute the
knowledge about the SPPB and accelerometry to a broader audi-
ence. The SPPB and accelerometry are speciﬁcally useful to study a
disease process affecting mobility and balance of patients. Degen-
erative diseases of the musculoskeletal system such as lumbar
spine disease or osteoarthritis of the major joints of the lower ex-
tremity are reasonable targets to study outcomes. Neurologicaldiseases affecting locomotion and balance are additional attractive
conditions to use the SPPB and accelerometry.
Based on these ﬁndings, we contend that the combination of the
SPPB and step count monitoring may be useful in routine clinic
settings, as well as research studies, to correlate the effects of an
intervention.Conﬂicts of interest
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